Lenalidomide-acetylene-Br is a PROTAC Linker taht makes up HJM-561 ( HY-156698 ). HJM-561 is a potent, selective, and orally active EGFR PROTAC to inhiibit Osimertinib ( HY-15772 )-resistant EGFR triple mutations.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > PROTAC Linkers
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.